PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F0EE1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $387,667
Award facts
- Contract value 100% obligated
- $387,666.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $387,666.68, was awarded on January 19, 2026, to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., for pharmaceutical and medical supply products to support federal medical procurement needs. The contract is non-set-aside and competitively awarded with firm fixed pricing. The prime contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain, fulfilling the place of performance at its corporate office location. The award is structured as a delivery order with an ultimate completion date of January 20, 2026, and falls under the parent company's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026.
Amerisourcebergen Drug Corp maintains an extensive portfolio of federal medical supply contracts, supplying a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains for military and veteran healthcare systems. The company's demonstrated capability to meet federal procurement requirements through open competition, combined with its role as a prime vendor under the DLA's Pharmaceutical Prime Vendor program, positions it as a major supplier of critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Defense Logistics Agency is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, which may reshape the competitive landscape for pharmaceutical distribution contracts.
Quick answers
Who was awarded contract SPE2D826F0EE1?
SPE2D826F0EE1 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 19, 2026.
How much is contract SPE2D826F0EE1 worth?
The government has obligated $387,667 on SPE2D826F0EE1.
Is contract SPE2D826F0EE1 an order under another contract?
Yes. SPE2D826F0EE1 is a delivery order under SPE2DX22D0030, an indefinite delivery contract.
Was contract SPE2D826F0EE1 competed?
The extent of competition for SPE2D826F0EE1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award